All medicines centrally authorised in the EU (EMA)
aflibercept
enzalutamide
Palbociclib
vamorolone
tarlatamab
nadofaragene firadenovec
hepatitis B surface antigen;Diphtheria toxoid;Bordetella pertussis antigens Pertussis Toxoid Filamentous Haemagglutinin;poliovirus (inactivated) type 1 (Mahoney) type 2 (MEF-1) type 3 (Saukett);Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) conjugated to Tetanus protein;tetanus toxoid
filamentous haemagglutinin;Haemophilus influenzae type B polysaccharide (polyribosylribitol phosphate);hepatitis B surface antigen;pertussis toxoid;poliovirus (inactivated) type 1 (Mahoney strain) produced on Vero cells;poliovirus (inactivated) type 2 (MEF-1 strain) produced on Vero cells;poliovirus (inactivated) type 3 (Saukett strain) produced on Vero cells;tetanus protein;tetanus toxoid adsorbed on aluminium hydroxide, hydrated;Diphtheria toxoid
sapropterin dihydrochloride
C02KX06
feline herpesvirus 1 (FHV), strain G2620A, live;feline calicivirus (FCV), strain F9, live;feline panleucopenia virus (FPL), strain MW-1;chlamydia felis, strain Baker, live;feline leukemia virus (FeLV) self-amplifying RNA (saRNA)-particle
Lecanemab
insulin glargine
trastuzumab emtansine
zanidatamab
Escherichia coli J5 inactivated;staphylococcus aureus (CP8) strain SP 140 inactivated, expressing slime-associated antigenic complex
lipegfilgrastim
paltusotine hydrochloride
vedolizumab
Page 16 of 134 • 20 of 2,678 Medicines